News Report · Infectious Disease

CDC Alerts on Drug-Resistant Salmonella From Moringa Products

July 24, 2026

Date

May 27, 2026

Topic

Salmonella outbreak linked to moringa products

Impact

Multiple recalls; drug-resistant isolates reported

Specialty

Infectious disease, Primary care

Clinical Perspective

Workflow Add a standard supplement-use question to intake forms and create a field to record brand and lot numbers so recalled-products can be identified and reported to public health.

Economics Early identification and testing of suspected cases can reduce downstream costs from hospital readmissions for invasive, drug-resistant Salmonella by enabling targeted therapy and public health containment.

Outcomes Prompt discontinuation of contaminated supplements, culture and susceptibility testing, and reporting should reduce progression to invasive disease and improve tailoring of antibiotic therapy for resistant isolates.

Dr. Omar Farouk · Infectious Disease

What Happened

The Centers for Disease Control and Prevention (CDC) issued a salmonella cdc 2026 alert linking multiple Salmonella infections, including extensively drug-resistant isolates, to moringa leaf powder capsules and related products [8][2]. The agency has identified and investigated at least two related outbreaks since January 2026 and has documented recalls of several brands, including Rosabella (Ambrosia Brands), Total Nutrition, and Mogo, with product removal notices issued in February and May 2026 [4][1][6]. CDC is advising consumers to check homes for recalled moringa products, to discard or return affected lots, and the agency continues active case finding and traceback investigations nationwide [3][8].

Why It Matters

Salmonella linked to moringa supplements poses a clinical problem for outpatient and inpatient clinicians because patients often perceive botanical supplements as low risk and may not report their use, creating missed exposure history and delayed diagnosis [8][3]. As of January 29, 2026 CDC reported 65 cases across 28 states in one outbreak, and subsequent investigations have added cases from separate but related events, raising the number of affected states and consumers exposed to contaminated products [5][8]. The presence of extensively drug-resistant Salmonella in at least one cluster raises concerns about empiric therapy choices for severe infections and potential need for specialist input for resistant isolates [2]. These outbreaks follow product recalls after laboratory confirmation of Salmonella in moringa leaf powder and capsules, so the change is driven by epidemiologic linkage, microbiologic testing, and identified contaminated lots now subject to recall actions [4][1].

What Changed

Previous situation: Consumers could buy moringa leaf powder and capsules at retail with no widespread warnings. New situation: Multiple recalls and a CDC food safety alert now advise consumers to check homes and discard or return specific recalled moringa products [8][1]. [8]
Previous oversight: Clinicians rarely screened for herbal supplement use in routine visits. New practice: Clinicians should now actively ask about recent moringa supplement use when evaluating febrile gastroenteritis or invasive Salmonella given ongoing outbreaks [3]. [3]
Previous infections: Most reported linked Salmonella were treatable with standard regimens. New concern: At least one outbreak involves extensively drug-resistant Salmonella, which changes empiric antibiotic considerations for severe disease and may require susceptibility-guided therapy [2]. [2]
Previous public guidance: Limited targeted recalls. New actions: Multiple manufacturers (Ambrosia Brands Rosabella, Total Nutrition, Mogo) have issued lot-specific recalls and CDC points to those recalled lots as not to be eaten, sold, or served [4][1][6]. [4]
Previous reporting: Routine public health follow-up for sporadic Salmonella. New requirement: Enhanced case finding and traceback investigations are underway and clinicians should report suspect cases promptly to local health departments for pulsed-field gel electrophoresis/whole-genome sequencing linkage [3]. [3]
Previous patient counseling: General food-safety advice. New counseling point: Patients should discontinue and discard recalled moringa products immediately, and clinicians should counsel symptomatic patients to seek testing and evaluation, especially if febrile or systemically ill. [6]. [6]

What This Means for Your Practice

Primary care clinicians, emergency physicians, infectious disease consultants and clinical pharmacists in ambulatory and acute-care settings should incorporate direct questions about moringa leaf powder and capsule use into histories for patients with gastroenteritis or febrile illness, document product brand and lot when available, and advise immediate discontinuation and disposal or return of recalled products; symptomatic patients should be tested for Salmonella and reported to public health for culture and susceptibility testing to detect drug-resistant isolates [3][6]. When patients present with signs of invasive Salmonella infection consider earlier infectious disease consultation if resistance is suspected or if empiric therapy may need adjustment pending susceptibility results, and ensure clear documentation of counseling and return/disposal instructions in the medical record — how will your clinic standardise capture of supplement brand/lot data and reporting workflows to local public health for suspected cases?

Sources and Further Reading

[1] CDC. Salmonella Outbreak Linked to Moringa Leaf Powder | Salmonella Infection. 2 days ago. URL: https://www.cdc.gov/salmonella/outbreaks/supergreenssupplementpowders-1-26/index.html

[2] CDC. Extensively drug-resistant Salmonella outbreak linked to moringa powder capsules | CDC Newsroom. February 13, 2026. URL: https://www.cdc.gov/media/releases/2026/2026-new-extensively-drug-resistantsalmonella-outbreak-linked-to-moringa-powder-capsules.html

[3] CDC. Salmonella Outbreak Linked to Moringa Capsules | Salmonella Infection. 1 week ago. URL: https://www.cdc.gov/salmonella/outbreaks/moringa-05-26/index.html

[4] CDC. Investigation Update: Salmonella Outbreak, February 2026 | Salmonella Infection. April 1, 2026. URL: https://www.cdc.gov/salmonella/outbreaks/moringacapsules-02-26/investigation.html

[5] CDC. New recall in Salmonella outbreak linked to dietary supplements containing moringa leaf powder | CDC Newsroom. January 29, 2026. URL: https://www.cdc.gov/media/releases/2026/2026-new-recall-in-salmonella-outbreak-linked-to-dietary-supplements-containing-moringa-leaf-powder.html

[6] CDC. Investigation Update: Salmonella Outbreak, May 2026 | Salmonella Infection. May 27, 2026. URL: https://www.cdc.gov/salmonella/outbreaks/moringa-05-26/investigation.html

[7] CDC. Investigation Update: Salmonella Outbreak, January 2026 | Salmonella Infection. 2 days ago. URL: https://www.cdc.gov/salmonella/outbreaks/supergreenssupplementpowders-1-26/investigation.html

[8] CDC. New Alert: Growing number of Salmonella illnesses and outbreaks linked to moringa leaf products | CDC Newsroom. May 27, 2026. URL: https://www.cdc.gov/media/releases/2026/2026-growing-number-of-salmonella-illnesses-and-outbreaks-linked-to-moringa-leaf-products-consumers.html

References